“…Following blocking, specimen were incubated for 48 h at 4 °C with primary antibodies against TNFR1 (mouse monoclonal antibody raised against amino acids 30–301 mapping within the extracellular domain of TNFR1, SC-8436, 1:250, Santa Cruz Biotechnology) or against TNFR2 (goat polyclonal antibody raised against the C-terminus of TNFR2, SC-1072, 1:500, Santa Cruz Biotechnology). To examine dural cell types that might express TNFR1 and TNFR2, double labeling were conducted in conjunction with another antibody to detect: 1) peripheral nerve fibers (Peripherin, Rabbit polyclonal antibody, 1:1000, Ab1530, Millipore, or CGRP, Rabbit polyclonal antibody, 1:1000 T-4032, bachem), 2) dural vascular endothelial cells (vimentin, Rabbit polyclonal antibody, 1:250, SC-5565, Santa Cruz biotechnology), or 3) resident macrophages (mouse monoclonal antibody, CD163, clone ED2, 1:500, MCA342, Serotec) as we described earlier [47]. For all indirect immunofluorescence, Alexa 594 and/or Alexa 488- conjugated secondary antibodies (1:200, Invitrogen,) were employed.…”